Mental Health
Conference Coverage
Arab Americans reluctant to seek depression care from psychiatrists
SAN DIEGO – New study results support focus on primary care for meeting the mental health needs of this population.
News
Cotempla XR-ODT approved for children, adolescents with ADHD
Methylphenidate for ADHD now comes in a more convenient disintigrating tablet.
News
Mydayis approved for teens, adults with ADHD
Treatment can lead to improved symptoms of ADHD that can last up to 16 hours, phase III studies show.
From the Journals
Brexanolone appears effective for severe postpartum depression
Women treated with brexanolone show marked improvement in their HAM-D score within 24 hours of the beginning of their infusion.
News from the FDA/CDC
Teens’ overall tobacco use falls, but e-cigs now most popular product
As the use of combustible tobacco products falls, e-cigarettes take the top spot as teens’ tobacco product of choice.
Conference Coverage
Novel female sexual dysfunction drug effective, phase III studies show
Bremelanotide, which is administered subcutaneously, addresses low female sexual desire that is biological in nature.
From the Journals
Depression not responsible for teen weight gain, but SSRIs may be
Is it depression or the SSRI that promotes weight gain in teens?
Conference Coverage
Tweaking CBT to boost outcomes in GAD
SAN FRANCISCO – Various forms of cognitive-behavioral therapy can help patients, but only half of patients improve.
From the Journals
Supportive parenting program reduced African American teen smoking
Parents can have a significant impact on adolescent smoking.
From the Journals
Brain amyloid may herald decline in cognitively normal seniors
But do the findings shed any light on beta-amyloid’s role in the development of Alzheimer’s disease?
Conference Coverage
Liraglutide produced cardiometabolic benefits in patients with schizophrenia
SAN DIEGO – Can the cardiometabolic risk factors associated with the use of some antipsychotic medications be prevented?